French agree on home dialysis rates:
This article was originally published in Clinica
Executive Summary
Following agreement with two industry associations focused on providing healthcare in the home, the French health ministry has issued a notice relating to the price and reimbursement levels for ambulatory dialysis equipment. The national healthcare products economics committee has entered into a contract with trade associations, Synalam and Snadom, which set a maximum price before tax for the sale to distributors that then sell directly to those insured socially. The maximum price for a programmable ambulatory insulin perfusion pump is E2,600 ($3,300), and the maximum price for a catheter and associated accessories is E17.53. The agreement also extends to the reimbursement price for each use of such a system, for monthly loans of the equipment, and to training costs.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.